Korro Bio, Inc. (KRRO) vs Rallybio Corporation (RLYB)

A side-by-side comparison of Korro Bio, Inc. and Rallybio Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — KRRO vs RLYB

growth of $100 · dividends reinvested · last 5y
KRRO -97.5% (-52.2%/yr)RLYB -85.0% (-31.6%/yr)RLYB compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020222023202420252026$2$15
KRRO RLYB

KRRO vs RLYB: by the numbers

  • •KRRO is the larger company ($97M vs $91M market cap).
  • •RLYB is profitable (7051.24% net margin) while KRRO runs a net loss (-4477.08%).

Metrics side by side

Valuation

MetricKRRORLYB
P/E ratioN/A2.19
P/S ratio40.78140.31
P/B ratio0.940.96
FCF yieldN/A29.06%

Profitability

MetricKRRORLYB
Gross margin33.04%89.28%
Operating margin-1366.43%-3270.86%
Net margin-4477.08%7051.24%
ROE-103.31%48.20%
ROIC-50.17%-24.40%

Growth (annualized)

MetricKRRORLYB
Revenue CAGR (5Y)-41.67%N/A
Total return CAGR (5Y)-50.72%-35.80%

Frequently asked

Is KRRO or RLYB more profitable?
RLYB runs the higher net margin — KRRO at -4477.08% versus RLYB at 7051.24%.
How have KRRO and RLYB total returns compared?
Over the past 5 years, KRRO delivered -50.72% and RLYB delivered -35.80% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.